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Abstract—Diffusion-weighted magnetic resonance imaging 
(DWI) is a key non-invasive imaging technique for cancer 
diagnosis and tumor treatment assessment, reflecting Brownian 
movement of water molecules in tissues. Since densely packed 
cells restrict molecule mobility, tumor tissues produce usually 
higher signal (a.k.a less attenuated signal) on isotropic maps 
compared to normal tissues. However, no general quantitative 
relation between DWI data and the cell density has been 
established. 
 In order to link low-resolution clinical cross-sectional data with 
high-resolution histological information, we developed an image 
processing and analysis chain, which was used to study the 
correlation between the diffusion coefficient (D value) estimated 
from DWI and tumor cellularity from serial histological slides of a 
resected non-small cell lung cancer (NSCLC) tumor. Color 
deconvolution followed by cell nuclei segmentation was performed 
on digitized histological images to determine local and cell-type 
specific 2d (two-dimensional) densities. From these the 3d 
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(three-dimensional) cell density was inferred by a model-based 
sampling technique, which is necessary for the calculation of local 
and global 3d tumor cell count. Next, DWI sequence information 
was overlaid with high-resolution CT data and the resected 
histology using prominent anatomical hallmarks for 
co-registration of histology tissue blocks and non-invasive imaging 
modalities’ data. The integration of cell numbers information and 
DWI data derived from different tumor areas revealed a clear 
negative correlation between cell density and D value. 
Importantly, spatial tumor cell density can be calculated based on 
DWI data. 
 In summary, our results demonstrate that tumor cell count and 
heterogeneity can be predicted from DWI data, which may open 
new opportunities for personalized diagnosis and therapy 
optimization. 
 
Index Terms—DWI, heterogeneity, histology data, 
histopathology, image analysis, tumor cellularity. 
I. INTRODUCTION 
ANCER is one of the leading causes of mortality 
worldwide. In the medical treatment of cancer, the 
histopathology of tumor specimens provides the basis for 
diagnosis and therapy-planning. However, biopsies reflect only 
very restricted tumor areas, which might be of impaired 
significance with regard to the majority of systemic tumor load 
and respective therapeutic approaches [1]. The second pillar of 
tumor characterization is non-invasive imaging, which yields a 
relatively low-resolution picture of the local tissue, mapping 
information from different components (such as water content, 
radiation attenuation, cell density, extracellular matrix density 
etc.) on voxel intensity values [2]. This reduction of 
information impedes interpretation of the images. An example 
for non-invasive imaging of ultrastructural information 
available in almost every clinical magnetic resonance imaging 
(MRI) is diffusion-weighted imaging (DWI). The potential of 
DWI on non-invasive prediction of cell density has become a 
research focus. DWI has been shown to be effective in 
assessing cancer treatment response [3]–[7]. DWI reflects the 
motion of water molecules in tissue. For example, higher 
packing of the cells is associated by a restricted random 
(Brownian) movement of water, which is associated by a higher 
(i.e., less attenuated) signal in DWI. Its voxel resolution is 
typically in the range of mm [8]. The water molecule 
diffusion-driven displacement levels probe the tissue structure 
at different scales, including intracellular, intercellular, and 
supra-cellular scales, the latter by sensing water molecule 
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movement in vascular networks [8]. Most often cell density is 
higher in the solid portion of the vital part of a tumor than in 
normal tissue, and thus diffusion is expected to be restricted due 
to densely packed tumor cells [9]. However, tissue 
microarchitecture and composition may to some extend 
influence the voxel intensity value. The relation between DWI 
intensity and cell density is not unique for all tissues.  
 The intravoxel incoherent motion (IVIM) model is an 
advanced method to separate diffusion and perfusion in DWI, 
in which the signal decay in each voxel can be described by: ( ) = (1 − ) ∙ exp(− ∙ ) + ∙ exp − ∙ ( + ∗) 	.  (1) 
Here, S(b)/S0 is the ratio of echo signal amplitude of 
diffusion-weighted to non diffusion-weighted intensity [10]. 
Parameter b defines the degree of diffusion sensitization, 
depending on magnitude, duration of the gradient pulse and the 
time interval between two successive pulses. The precise 
mathematical relation depends on the shape of the pulses [11]. 
D is the diffusion coefficient, characterizing the restricted 
mobility of water molecules, for example in intercellular spaces. 
D* >> D is the pseudo-diffusion coefficient related to blood 
flow in the capillary network, that in a voxel often has a 
pseudorandom orientation. f is proportional to the blood vessel 
volume fraction.  
  Different attempts have been undertaken to relate S/S0 to 
tissue characteristics. A common approach uses instead of the 
bi-exponential function a fit to only one exponential, ( )/= exp(− ∙ ). ADC lumps together contributions from 
water movement by diffusion and perfusion within the voxel 
(and is thus called apparent diffusion coefficient) [8], [10], 
hence it is inherently less accurate in probing true diffusion. 
Changing b changes the weight of the terms; at large b true 
diffusion is probed to a greater extend. 
 So far, a few studies comparing DWI and histological 
information have been performed [12]–[17]. In [12], Kono et al. 
computed the average ADC vs. the expectation value of the 
nuclear area fraction in patients with brain tumors, representing 
each patients by one single point in the graph. Histological 
evaluation was performed on selected sample images. The 
same quantity was computed by Hayashida et al. [13] for 
metastases of different primary tumors in brain. Lyng et al. [14] 
considered human melanoma xenografts in mice, calculating 
ADC vs. manually detected cell density for different tumors 
and different regions within the same tumor. Anderson et al. 
[15] computed the ADC vs. cell volume fraction in cell 
suspensions and packed arrays of human glial and red blood 
cells. Ginat et al. [16] correlated the manual estimated cell 
densities with ADC values measured in different patient tumors 
to differentiate benign from malignant skull lesions. Schmainda 
[17] investigated the utility of ADC in diagnosis and treatment 
in glioma based on the inverse correlation between ADC and 
tumor and tissue cell density. In each case, a negative 
correlation between the ADC value and the measure 
characterizing cell density in the histological or in-vitro 
samples was found [12]–[17]. Among these studies, the 
histology analysis was performed either manually or by simple 
image processing tool that used global thresholding, which is 
sensitive to errors [12].  Besides, the quantitative analysis was 
limited to only a small number of histological slices.   
 Some investigators compared simulated cell density 
differences to relative ADC values, to estimate tumor cell 
numbers. The studies were based on the negative correlation 
and tumor growth mathematical models [18]–[21]. For 
example, Atuegwu et al. [18] estimated the growth rate for 
brain cancer in rat based upon a logistic growth model in each 
voxel in combination with the ADC. Weis et al. [19] estimated 
the cellularity in human breast cancer from a Fisher-KPP 
equation with the local ADC coupled to the mechanical stress 
modified by the growing tumor, using the maximal number of 
cells fitting within a voxel as fit parameter. Further applications 
based on [19] were proposed in [20] for response of breast 
cancer to neoadjuvant therapy and in [21] for glioma growth in 
rat brain.  
 Most studies address animal tumors or xenograft [14], [15], 
[18], [21], [22] and consider mean values for the individual 
tumors without statistical quantification of variation. Moreover, 
the ADC value lumping perfusion and diffusion was used [23]. 
The ADC is usually computed as the mean measurement of 
different regions of interest (ROIs) [12], [13], [16] or on each 
voxel of one large (tumor-size scale) ROI [18]–[21] on one 
MRI slice without further consideration of the local tumor 
micro-structure. 
 In this study we investigate both, the diffusion value D vs. 3d 
(‘d’=dimension) cell density relation, and the D vs. area 
fraction relation for a single patient non-small cell lung cancer 
(NSCLC) tumor. By using D instead of ADC we inherently 
address diffusion only, hence avoid lumping diffusion and 
perfusion together. ADC is formally equivalent to D when f is 
zero. In our study given the ranges of b and f, ADC is not equal 
to D. Besides, ADC is approximately equal to D at very large b 
values by eliminating the effects of perfusion. However, the 
increase of b leads to a higher probability of lower SNR. 
 For our analysis we developed an automated image 
segmentation pipeline as this facilitates analysis of large 
histological samples necessary to reduce statistical errors. A 
large variety of methods have been proposed for cell nuclei 
segmentation on cancer histological images [24]. Popular 
approaches to segment cell nuclei include the Hough transform 
[25] , voting along the direction of the image gradient to infer 
the center of the object [26]–[28] separating clustered nuclei 
along points of high concavity [29], [30], unsupervised 
Bayesian classification [31]  and supervised methods [32]. Our 
algorithm combines the image local intensity minimum and 
gradient information to detect the cell nucleus with low staining 
quality, such as irregular nucleus contour, small fragments 
inside individual nucleus, which can be detected as multiple 
nuclei by the previous mentioned algorithms. We use KL1 
staining as cancer cell marker to ensure identification accuracy 
between cancer and non-cancer cells within the tumor. The 
code can be downloaded at msysbio.com/cellsegmquant 
(integration into software TiQuant [33] is envisaged).  
 The automated segmentation is in-line with the aims of 
digital pathology. The routine analysis of tissue samples 
performed by pathologists is tedious, subjective, and time 
consuming. Tissue slides are digitized for quantitative analysis 
 
based on image processing techniques and automated analysis. 
The later increase speed and reproducibility of cancer 
evaluation and staging. By sampling from different locations of 
the same tumor we infer a relation between D values vs. 3d cell 
density and area fraction, respectively, for one single tumor 
alone, that span a surprisingly large range of values hence 
displaying a significant degree of heterogeneity. The findings 
suggest that tumor heterogeneity in individual patients can be 
detected non-invasively. 
 In summary, the novelties of this work comprise: study in 
human lung tumor with large heterogeneity; efficient algorithm 
for nuclei detection and application to tumor cells; proposed 
ellipsoid model based algorithm for 3d cell density estimation; 
cancer and non-cancer cell-count on 350 whole histology slides; 
investigation of heterogeneity within an individual tumor from 
DWI; correlation between diffusion coefficient assessed by the 
IVIM model in DWI and cell density; counting of total cell 
number of tumor based on this correlation. The paper is 
structured presenting first the data acquisition, then the 
methods to analyze them. The results on the histological and 
DWI data analyses follow, along with the correlation. The 
paper ends with discussion of the results in light of the literature, 
and the limitations of the study, as well as concluding remarks. 
II.   DATA ACQUISITION  
A. Patient Selection and Tissue matching 
Primary human NSCLC tissue was obtained from a patient as 
part of a patient cohort who underwent a lobar resection for 
lung cancer at the Department of Thoracic Surgery, 
Thoraxklinik Heidelberg-Rohrbach (Germany). Informed 
consent was obtained from the patient (Appendix-A). After 
tumor resection the patient underwent adjuvant radiation 
therapy. 
The tumor was selected for the following reasons. It showed 
invasion into the pericardial fat, which made it immobile during 
breathing excursions, thus reducing the effects of respiratory 
motion during cross-sectional imaging and avoided difficulties 
in the identification of tumor sub-volume locations. Centrally 
the contact between the tumor and the large bronchial structures 
(diameter of about 5-6mm) could be used to reliably and easily 
orient the tumor after resection. The bronchial structures were 
located within the axial planes of the CT and MRI (Fig. 1(a), 
(b)), to co-register the different imaging modalities (CT and 
MRI).  
Further serial sections were performed in parallel to the axial 
cut with thickness of each section of approximately 1 cm. The 
tumor tissue slice (Fig. 1(c)) selected for further work-up, was 
the one above the central cutting line of the tumor, and 
contained all relevant tissue and cell types of the tumor such as 
normal lung tissue, vital tumor tissue, and surrounding adipose 
tissue. Relevant MRIs were acquired in axial plane identical to 
the selected tumor slice (Fig. 2), based on which the tumor 
tissue was classified. Identification of central necrosis was 
based on DCE-dynamics and Ktrans (volume transfer coefficient 
reflecting vascular permeability) value from DCE-MRI (Fig. 
2(a)) which has the same coordinate system and structural 
images as the other MRIs. The functionally identified borders 
of the necrosis (the central area being not perfused) were 
transferred to the high resolution T1-contrast image (Fig. 2(b)). 
The outer border of the tumor (Fig. 2(b)) was manually 
segmented based on contrast differences. 
 
Fig. 1.  Selection of patient tumor. (a) CT slice; (b) Corresponding T1-weighted 
MRI slice; (c) Tumor tissue slices, the one which was selected for further 
analysis is highlighted. The white rectangle delineates the analyzed strip 
(Fig.10(a)). Tumor diameter is 6.5cm (black double arrow on (a)). The chronic 
inflammation is indicated by the enlarged diameter of the bronchial structures 
up to the periphery (white arrow on (b)). 
For further analysis, the tumor slice was cut into smaller 
pieces. Seven tissue samples were cut from the tumor strip 
delineated by a white rectangle as shown in Fig. 1(c) and Fig. 
10(a). The cutting line (Fig. 1(c)) was drawn from the extension 
of bronchus III through the center of the necrosis towards the 
most distant part of the adipose tissue invasion by the tumor. 
Based on the cutting line, histological samples were visually 
matched to fit the structures identified in MR/CT. Fine 
calibration was done by careful evaluation of the multimodal 
contrast with regard to specific tissue types in the MRI to select 
the pixels that correspond to the histological specimens. This 
procedure was several times repeated ensuring reproducibility. 
 
 
      
Fig. 2.  Tissue classification based on functional MRI: (a) Perfusion kinetics of 
DCE-MRI (the colorbar indicates the Ktrans values displayed in the tumor 
region); (b) Necrotic tumor contour (necrosis from (a)) overlaid on 
T1-CEFS-MRI. The outer thin line delineates the tumor region. The vital tumor 
is in-between. 
 
B. DWI 
Within a clinical standard thorax MRI [34] including a tumor 
perfusion contrast dynamic MR-image [35] a navigated 
diffusion echo-planar imaging sequence was used acquiring 6 
b-values above zero = 50, 100, 150, 200, 400, and 800 s/mm2. 
The diffusion-encoding gradients were applied in three 
orthogonal directions; therefore the diffusion tensor is assumed 
isotropic. The sequence used the following parameters: TE 75 
ms, TR 8364 ms, SL 6 mm. Imaging was performed on a 1.5 T 
MRI (Avanto, Siemens, Erlangen). The DWI voxel resolution 
is 2.1 mm × 2.1 mm × 6 mm. The D value of each voxel was 
obtained by fitting the voxel signal S/S0 vs. the b-value to the 
above signal attenuation model (1) using the freely available 
software MITK Diffusion [36]. For the determination of the 
tissue diffusion coefficient, all above b-values were taken into 
account. 
C. Materials 
1) Tissue sampling and processing 
After fixation of the tissue slice (about 7 cm × 5 cm × 0.5 cm) 
in 4% buffered formalin overnight, the sample was cut in 
smaller pieces (about 1 cm × 1 cm × 0.5 cm), transferred in 
paraffin, and systematically cut in 1-2 μm thick sections using a 
microtome (HM 355, Microm, Thermo Scientific, 
Braunschweig, Germany). Selected samples were stained with 
hematoxylin/eosin (H&E) and carefully reviewed by the study 
pathologist (A.W.) to determine the proportion of viable tumor 
cells, stromal cells, normal lung cell content, infiltrating 
lymphocytes, and necrotic areas. 
2) Sample staining 
Sections were stained using hematoxylin/eosin (H&E) and 
acid fuchsin orange G (AFOG) standard protocols. In addition, 
an anti-pan cytokeratin antibody (clone KL1, Abcam, 
Cambridge, UK) was used for epitope-specific stain. In brief, 
staining was performed using the Dako Autostainer (Dako, 
Hamburg, Germany) and the following protocol: tissue slides 
were air-dried in an incubator at 42°C overnight and 
deparaffinized in xylene (2 × 10 min). After rehydration in 
graded ethanol, the slides were pretreated in 0.01 M sodium 
citrate (pH 6.0) in a pressure cooker for 10 min. Afterwards, 
primary antibodies in PBS/Tween were added for 30 min at 
room temperature and slides were washed with PBS/Tween for 
5 min before the secondary antibody was applied for 20 
minutes (1:1.000 in PBS/Tween). The samples were then 
incubated with 1% hydrogen peroxide diluted in PBS/Tween (5 
min). After signal detection using amino-ethyl-carbazol (AEC, 
2 × 7 min) nuclei were stained using hematoxylin. 
3) Image acquisition 
Glass slides were automatically scanned in bright-field mode 
at a 40-fold magnification (0.23 μm/pixel) with the Hamamatsu 
NanoZoomer 2.0-HT Scan System (Hamamatsu Photonics, 
Hamamatsu, Japan). The imaging system consists of three 
4096×64 pixel TDI-CCD sensors (sensor pixel size: 8 µm2), 
providing manual/automatic adjustments of the number of 
focus points and multiple plane digitization [37]. For the 
scanning of the object slides, the slide scanner automatically 
detects the ROI that contains the tissue and also determines 
automatically a valid focal plane for scanning. Resulting virtual 
slides have an average compressed file size of 1 GB (JPEG, Q = 
90) and uncompressed of about 25 GB, depending on the 
scanned area. 
III. DATA ANALYSIS METHODS 
Based on the tumor DWI and histology data, we developed a 
processing pipeline for tumor cellularity estimation. The 
pipeline includes: 
1. 2d cell density estimation based on histological image 
analysis. A segmentation algorithm is proposed to detect 
cell nuclei in histological images. Each cell is assumed to 
have only one nucleus, and the 2d cell density is obtained 
by dividing the number of detected nuclei by the area of the 
tissue slide. The analysis tool enables the automated 
quantification of cellularity in large histological samples 
with high accuracy.  
2. 3d cell density estimation in a two-step process. The first 
step involves the computation of 3d cell densities from 2d 
segmentations separately for cancer and non-cancer cells 
based on a model that approaches cell nuclei shapes by 
ellipsoids. Next the total 3d cell density is computed 
involving both cancer and non-cancer cells. This is 
necessary to estimate the tumor cell load for the entire 
tumor as well as on a voxel-wise basis.  
3. Correlation of the DWI-images and tumor cellularity in 
both 2d and 3d by comparison of diffusion coefficients and 
cell densities of seven selected tumor tissue samples. The 
correlation is used to calculate the tumor cell load in each 
voxel of the DWI data for analysis of tumor heterogeneity, 
which includes calculation of the cell distribution in tumor 
regions for which no histology data is present as well as for 
cell load estimation of the entire tumor. 
4. Cell number estimation of the whole tumor. The tumor 
contour and volume are obtained by tumor segmentation in 
DWI data. The 3d cellular distribution of the tumor can be 
estimated from the D value distribution based on the 
relationship between D value and cell density in step 3. 
The total cell number is finally obtained by summing up 
the cell numbers in all those voxels of the DWI data that 
belong to the tumor. 
A. Histological image analysis 
We propose an automated algorithm for the detection and 
classification of cells in tumor tissue based on H&E staining for 
all nuclei, and KL1 staining for cancer cytoplasm. The 
algorithm depicted in the flowchart of Fig. 3 was tested on 
digitized histological slides. 
1) Pre-processing 
The original histological image is at 40-fold magnification 
with file size of larger than 1 GB. To trade-of visible details and 
computation time, a magnification of 20-fold was chosen 
(0.455 µm/pixel) for all images for histology analysis. In the 
cutting process, the spatial correspondence between neighbor 
tissue slides is lost and information from different slides is 
difficult to compare. Before analyzing the data quantitatively, 
the scanned histology slides were preprocessed once with, once 
 
without image registration [38] (see Table I). The Gaussian blur 
was applied to reduce the noise in both cases. Data represented 
below are for registered images. 
 
Fig. 3.  Flowchart of the image analysis algorithm for automatic histology study, 
from serial histology slides to 2d cell density evaluation. The left column 
indicates the corresponding sub-sections in Section III. A. 
2) Color deconvolution 
An automated color deconvolution [39] was performed in the 
histological image after pre-processing to split the color image 
into hematoxylin and KL1 channels. The KL1 channel image 
was used to generate a mask image, which separated the cancer 
sensitive region from the background. The final detected nuclei 
were then classified into cancer and non-cancer nuclei based on 
the mask image. From the hematoxylin channel image, we then 
implemented an automatic cell segmentation algorithm. 
The color deconvolution method assumes that a pixel is a 
weighted sum of 3 stains, the two stains hematoxylin and KL1, 
and the background. Each stain  has its own characteristic 
absorbance for light in each of the three RGB channels =	 { , , }.  For channel , based on Lambert-Beers law, 
Ruifrok et al. [40] proposed for the intensity of light after 
passing a tissue sample in a bright field micrograph the relation = , ∑ , ,         (2) 
where ,  is the intensity of light entering the specimen in color 
channel =	 { , , } ; 	 ,  is the corresponding absorption 
factor, and  is the concentration of the stain . With incident 
white light , = 255 for each channel =	 { , , } the optical 
density reads = ∑ , = 	− , .                     (3) 
The optical density of the color image is expressed as = , 
where  is a three-element vector denoting the optical density 
of each of the RGB channels. A is a three-by-three absorption 
matrix, of which the rows indicate the different RGB channels 
and columns indicate the different stains. C is a three-element 
vector representing the concentration of each stain. Once  is 
determined, the color deconvolution scheme is applied 
according to  =	 	 .                (4) 
In our study, there are two principal stains, hematoxylin and 
KL1. The optical densities of the specific stains were obtained 
by an automatic singular value decomposition (SVD) method, 
based on which the absorption matrix  was created following 
the process detailed in [39]. The color deconvolution was then 
performed to separate the hematoxylin and KL1 channels as 
shown in Fig. 4(b), (c). 
3) Cell nuclei segmentation 
To segment cells on histological images with high accuracy 
is a big challenge, since cells have high variance in size and 
shape. In addition, artifacts coming from the histological image 
preparation (tissue slice cutting and staining) further impede 
cell segmentation. In this paper, we implemented a seed based 
automatic and robust cell segmentation algorithm which is 
composed of two steps. The first step was to automatically 
locate the center of each cell using local intensity minimum and 
gradient information [26]. Cell centers detected in the first step 
were then used as initial positions for the second step for 
nucleus segmentation and nucleus contour extraction. 
To determine the seed points, only the hematoxylin channel 
(Fig. 4(b)) extracted above by color deconvolution from the 
color image (Fig. 4(a)) was used, as including KL1 staining 
reduced contrast. The hematoxylin channel was converted into 
a gray scale field ( , ) (Fig. 4(d)). The image gradient was 
computed with the Sobel operator. Its direction is from the 
center of a nucleus to the outside. The gradient for each pixel 
was used to compute a voting area (Fig. 4(f)) denoting the most 
probable (candidate) nuclei region as follows: for each 
pixel( , ), the “voting direction” ( , ) is defined as  = ∇ ( , )‖∇ ( , )‖ = − cos ( , ) , sin( ( , )) ,   (5) 
where ( , )  is the gradient, ‖∇ ( , )‖  is the gradient 
magnitude, and  is the angle of the gradient direction with 
respect to x-axis. The voting area ( , ; , , ) of 
each pixel is defined by an annular sector with its vertex 
at	( , ) as illustrated in Fig. 4(f). Based on the approximated 
mean nuclei diameter (5	μm),  was set to 1.25	μm, and 	was set to 3.75	μm.  is the angular range and set to 30 . 
Those regions where voting regions of different pixels overlap 
are likely to be nuclear center regions (Fig. 4(f)). A region 
overcoming a certain threshold was considered as center 
region, whereby the threshold was chosen to ensure one center 
region per nucleus. We defined the nucleus seed point as 
centroid of the region. The final nuclei segmentation was 
obtained by an active contour method [41] using the detected 
nuclei seed points (Fig.4(g)). 
B. 3d cell density estimation with an ellipsoid model 
The 3d cell density is estimated in a two-step process. First, 
we analyze how 2d and 3d cell densities relate for a given cell 
type (cancer vs. non-cancer cells). Second, based on these 
relationships, the total 3d cell density is computed combining 
the number of cancer and non-cancer cells (this will lead to (7) 
in Section IV.D). The first step is the focus of this section, 
while the results for the two steps are given in Sections IV B, D.  
An iterative optimization method is proposed to estimate the 
nuclei distribution in 3d using the 2d nuclei features of a given 
cell type. Our method estimates a statistical distribution of cells 
in 3d space but cannot give their true 3d spatial distribution. 
2D cell density 
Pre-processing
Nuclei segmentation 
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Serial histological 
images 
Color deconvolution 
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Fig.5 illustrates the 3d density estimation algorithm that will be 
applied in section IV.B.  
Our method is based on the observation that the shape of a 
cell nucleus in 2d is approximately elliptical [27], [28], [42]. 
Accordingly we assumed that nuclei in 3d are ellipsoids [43], 
[44] (Fig. 5(a)). 
 
 
 
Fig. 5. Illustration of the conceptual idea underlying the 3d cell density 
estimation: (a) The elliptic nuclei contours in the 2d histological image (3 red 
circles) are assumed to represent cuts of 3d ellipsoidal nuclei. (b) If the 
ellipsoids are distributed in a 3d model tissue volume, (c) virtual cuts through 
the 3d virtual tissue volume (yellow plane in (b) and (c)) should statistically 
reproduce the shape distribution of 2d cross-sections from (a) indicated by the 
red cut contours in the bottom of (c) provided that the axis lengths and density 
of the ellipsoids are properly chosen. 
The 2d cell density and nuclei size distribution are calculated 
based on the 2d nuclei segmentation results on the histological 
images. The 2d contours of detected nuclei are fitted by ellipses 
with semi-major axis a and semi-minor axis b. As nuclei 
contours are of different size, this leads to nuclei size 
distributions f(a), h(b), respectively. We assume that the 2d 
contours emerge from cross sections of ellipsoidal shaped 
nuclei in 3d whereby the ellipsoids have semi-axes a’, b’ and c’ 
(Fig. 5(a)). The axes are determined empirically requiring that: 
(i) the density of objects in virtual 2d cross sections through a 
3d volume (Fig. 5(b)), into which the ellipsoids were 
homogeneously distributed and isotropically oriented, shall 
reproduce the 2d density in the data (Fig. 5(b),(c)); (ii) the 
distribution of semi-major and semi-minor axes in the virtual 
2d cross sections should reproduce the expectation values 
〈 〉, 〈 〉 and the variances 〈( ) 〉	, 〈( ) 〉	obtained from the 
data. For this an iterative procedure is used (Algorithm 1) 
where the ellipsoid axes are drawn from normal distributions: ′~ ( , )′~ ( , )′~ , .      (6) 
As starting values of the iteration, values = 〈 〉, =〈 〉 , =	 〈( ) 〉 , and = 〈( ) 〉  are used and 
stepwise adjusted until the upper conditions (i) and (ii) are 
fulfilled. Notice that this choice is neither unique, nor 
compulsory. For example, it neglects a possible correlation 
between major and minor axes in the 2d section and in 3d 
(through the nucleus volume for which we do not have data). 
However, we validated the algorithm with liver tissue for which 
we could reconstruct the 3d volume data from optical sections 
of confocal laser scanning micrographs, and we verified the 
algorithm with synthetic data on elongated cell nuclei shapes, 
with both homogeneous and inhomogeneous distributions of 
cell nuclei (Supplementary1-A). 
Algorithm1: 3d cell density estimation 
Input parameter:  
• : target nuclei density in 2d measured by image analysis 
• ∆ : target accuracy of result. (Choose e.g. ∆ = 0.1 × ) 
• Semi-axes distribution of cell nuclei in 2d 
Algorithm: 
1. Define a cube with a given volume  
2. Distribute  cells (ellipsoids) in the cube  
• Axes of ellipsoids are determined by 2d axes distribution; 
adjusted to meet condition (ii)  
• Prevent nuclei overlapping 
3. Obtain resulting average 2d cut cell density  
4. If (| − | < ∆ ) 
{    Meet condition (i) and compute resulting 3d density:  
 
1  Supplementary materials are available in the supplementary files 
/multimedia tab. 
Fig. 4.  Automatic cell nuclei detection: (a) histological color image was separated into (b) hematoxylin (cell nuclei in blue) and (c) KL1 (cancer cell sensitive 
regions in brown) channels; based on the grey level image (d) (converted from the hematoxylin channel) and the binary mask image (e) (extracted from the KL1 
channel), candidate nuclei regions (green) (f) were obtained; the final segmentation result (g) including the cancer nuclei (red) and non-cancer nuclei (blue), the 
small window on the right shows the nuclei contours and center points inside the zoom region. 
 
(3 ) = ⁄  (End result of computation)} 
Else if ( < ) 
{    Increase  ( = + ∆ ) 
Remove existing nuclei and restart with 2.} 
Else 
{    Decrease  ( = − ∆ ) 
      Remove existing nuclei and restart with 2.} 
C. Cell number estimation by correlation between diffusion and 
cellularity 
 The tumor cell number was calculated based on tumor voxels’ 
D values and the identified correlation between diffusion and 
cellularity. Fig. 6 illustrates the mapping from D value to local 
cell density: the high D value voxel has low cell density, while 
the low D voxel has high cell density. The correlation and cell 
number counting scheme are explained in detail in Section IV. 
 
 
Fig. 6.  Mapping from D value to local cell density. T1-MRI overlaid with the D 
parametric map of the selected tumor (left), the colorbar indicates the D values 
displayed in the tumor region; high D value corresponds to low cell density 
(sparsely distributed nuclei) while low D value corresponds to high cell density 
(densely distributed nuclei) 
IV. ANALYSIS RESULTS 
A. Cell segmentation and classification evaluation 
The proposed automatic cell segmentation algorithm 
performs high detection accuracy (Fig. 7); this was confirmed 
by the study pathologist whose evaluation served as ‘diagnostic 
standard’. For this, we selected 20 representative histological 
images, and then compared the detected results by the proposed 
method with the manual results. First we validated the cell 
segmentation, and then among the detected cells, the cell 
classification in cancer versus non-cancer cells. The TP, TN, 
FP, and FN (T=true, F=false, N=negative, P=positive) of cell 
segmentation are defined in Supplementary1-B. Fig. 7(a) shows 
the ROC graph for the cell segmentation (blue solid triangles) 
and classification performance of identifying cell types (red 
solid circles) for the 20 registered images (each represented by 
a symbol). The results indicate high sensitivity (=TP/(TP+FN)) 
and specificity (=TN/(TN+FP)) in all cases. Table I lists the 
corresponding mean values and standard deviations of 
sensitivity, specificity and accuracy 
(=(TP+TN)/(TP+FP+FN+TN)). The proposed algorithm has a 
high mean accuracy for cell segmentation and cancer cell vs. 
non-cancer cell classification (up to 0.963) illustrating that the 
algorithms can reliably detect and identify individual 
cells/nuclei in the histological sections. The analysis was later 
done on 10 original images: there seems to be no influence of 
the cutting procedure (spatial distortion) on the cell counts. 
 
  
Fig. 7.  Evaluation of cell segmentation and classification. (a) ROC graph for 
performance of cell segmentation (blue solid triangle) and classification (red 
solid circles). (b) One sample of the result image: tumor cell nuclei are stained 
in blue (Hematoxylin), the cancerous regions are stained in brown (KL1), the 
red points indicate the detected cancer cell nuclei center points, while green 
points indicate the non-cancer cell nuclei. The algorithm can reliably detect 
individual nuclei even in areas with high cell density. For example in circle 1 
individual nuclei are recognized in areas with visually overlapping nuclear 
structures. In addition, individual cytokeratin positive tumor cells (circle 2) and 
stromal fibroblasts (circle 3) can be detected. 
 
TABLE I 
EVALUATION OF THE CELL SEGMENTATION AND CLASSIFICATION ON 20 
SELECTED REGISTERED AND 10 ORIGINAL HISTOLOGICAL IMAGES (0.47mm ×0.47mm): FROM LEFT TO RIGHT EXPRESSED AS MEAN ± THE STANDARD 
DEVIATION, SENSITIVITY, SPECIFICITY, AND ACCURACY. 
B. 3d cell density estimation: cancer vs. non-cancer cells 
 First, in order to investigate the 3d cell density, we fitted 
ellipses to the segmented nuclei in the histological images and 
computed the semi-major and semi-minor axes in the 2D slices 
for all blocks obtaining the distributions in Fig. 8. The pooling 
from all slices is justified, as not only the intra-block but also 
the inter-block variability of the ellipse axes is small (see 
Supplementary1-C). The average values and the variances of 
semi-axes over all the blocks were used for computation of the 
parameters a’, b’ and c’ as explained in Section III.B.  
   To probe the relationship between 2d and 3d cell densities for 
the selected tumor, we mimicked the cell distribution in the 
tumor volume and the tissue cuts. We assumed the 2d cell 
density for each cell type (cancer or non-cancer cells) 
increasing from 1 cell/mm2 to 6000 cell/mm2 by step 1 
cell/mm2. For each of the given 2d density value, we estimated 
the corresponding 3d cell density according to Algorithm1. We 
defined a cube V with edge length of 1 mm, and then 
distributed a number of ellipsoids in V in random locations and 
orientations, according to distributions a’, b’ and c’. The 
estimated 2d cell density is defined as the number of ellipsoid 
sections on the virtual cutting plane (Fig. 5(c)) divided by the 
area of the cutting cross-section. The estimated 3d cell density 
equals the number of ellipsoids divided by the volume	V. The 
Performance Sensitivity Specificity Accuracy 
Results on registered images 
Cell segmentation 0.954 ± 0.026 0.946 ± 0.042 0.953 ± 0.017 
Classification 0.947 ± 0.030 0.968 ± 0.022 0.963 ± 0.017 
Results on original images 
Cell segmentation 0.950 ± 0.023 0.943 ± 0.029 0.947 ± 0.016 
Classification 0.956 ± 0.056 0.952 ± 0.026 0.954 ± 0.032 
 
estimation was repeated for 10 times for each of the given 2d 
cell density. Finally, by plotting the estimated 3d cell density 
against the given 2d cell density for each estimation, a linear 
relationship was indicated for each cell type, =  
with ∈ { , } for cancer and non-cancer cells, respectively 
(Fig. 9, showing the data points with 3d density ranging from 
about 1000 to 320,000 cell/mm3). The least-square regression 
lines were drawn for both cancer and non-cancer cases. For 
cancer cells the slope =96/mm (goodness of fit: R =0.9997),  while for non-cancer cells 	 	 = 115/mm 	(R =0.9996). 
 
 
Fig. 8.  Elliptical semi-major (left) and semi-minor (right) axes distributions in 
2d histological images for cancer cells (in red) and non-cancer cells (in blue). 
For cancer cells, the average semi-major axis is	4.38	μm	( = 	1.62	μm); the 
average semi-minor axis is 2.68	μm	( = 0.9	μm). For non-cancer cells, the 
average semi-major axis is	3.85	μm ( = 1.92	μm); the average semi-minor 
axis is	2.05	μm	(SD= 0.66	μm). 
  
Fig. 9.  Linear relationship between 2d and 3d cell densities for both cancer and 
non-cancer cells. The slope of the line depends on the cell size (the semi-major 
and semi-minor axes of cell nuclei), the larger the cell (cancer cells) the lower 
the slope. 
C. Tumor homogeneity analysis: cell density distribution and 
cancer region fraction 
 The representative tumor samples (Fig. 10(a)) are selected 
for the study of the tumor homogeneity and cellularity. The 2d 
cell density was tested for significant differences among the 
selected tumor samples (S1-S7) with the Kruskal-Wallis test 
[45]. For each tumor sample, 50 histological slides uniformly 
distributed through the tumor block were selected for the 
statistical test. The null hypothesis (H0) is that there is no 
significant difference of cell density among tumor samples (the 
tumor is homogeneous). The hypothesis was rejected, as the 
difference is statistically significant (p ≪ 0.001). The tumor is 
thus heterogeneous. 
 The cancer region area fraction of tumor samples is 
presented by plotting the cancer (KL1 positive) region area 
against the non-cancer (non-KL1 positive) region area as 
shown in Fig. 10(b). The tumor sample S3, which is the closest 
to the necrosis region, has the highest cancer region fraction, 
while the tumor samples with lung tissue S1 and with fat tissue 
S7 have lower cancer region fractions. In case of a 
homogeneous tumor, all points on Fig. 10(b) would be on one 
straight line. 
 
 
Fig. 10.  Heterogeneity of the tumor: (a) overview of the tumor samples (S1-S7); 
(b) comparison of the cancer region fraction between different tumor samples 
by plotting the cancerous (KL1 positive) region area against the non-cancerous 
(non-KL1) region area, for 50 slides per tumor block. The yellow solid point 
denotes the average for the respective tumor sample. 
D. Correlation between D value and cell density 
 To investigate the correlation between diffusion and 
cellularity, we performed quantitative analyses of D values and 
cell densities of the selected tumor samples (Fig. 10(a)). Table 
II lists the D values of different tumor samples, which were 
calculated by performing IVIM estimation on the ROIs of the 
tumor samples on DWI (Fig. 11). The values of the fitted f and 
D* are given in Supplementary1-D. The average goodness of fit 
(R2) of (1) to our data is 0.91, and the corresponding standard 
deviation is 0.06. The 2d cell density (cancer and non-cancer 
cells together) of each tumor sample is the mean cell density of 
the 50 histological slides uniformly distributed through the 
tumor block. 
 
TABLE II 
D VALUES (MEAN AND STANDARD DEVIATION (SD) IN (10 / )) OF THE 
DIFFERENT TUMOR SAMPLES DEFINED IN Fig. 10(a) 
 
  
Fig. 11.  ROIs on DWI corresponding to the seven tumor samples (Fig. 10(a)). 
The shapes of the histological specimens were translated back to the DWI data 
by manual co-registration. Necrosis has been identified from T1-CEFS-MRI 
(Fig. 2(b)). 
Drawing the 2d cell densities of tumor samples against the 
corresponding D values exhibits a strong negative linear 
correlation (Fig. 12). The Pearson product-moment correlation 
test was performed to evaluate the linear correlation. The tumor 
sample S3 is next to the necrosis region (Fig. 10(a)), which has 
the highest tumor cell density with lowest diffusion coefficient. 
S1 includes part of healthy lung tissue. Because of the alveoli of 
lung tissue, there are cell-free regions in S1; this reduces the 
cell density and allows high mobility of water molecules (high 
diffusion). S7 is located at the tumor boundary where it has 
grown into the pericardial fat. A typical fat cell is quite big. For 
example, the white fat cell is 0.1 mm in diameter [46], which is 
the major form of adipose tissue in mammals. Therefore, fat 
tissue has low cellularity. Besides, we found a negative 
correlation for the 2d nuclei area fraction (total area of nuclei 
sections divided by area of tissue (Atissue) for each sample slide) 
and the 2d cell area fraction (total area of cell sections divided 
by Atissue) vs. the D value (see Supplementary1-E and -F). 
  
Fig. 12.  Correlation between D value and 2d cell density. The Pearson 
correlation coefficient (γ ) is −0.84 , representing a strong negative linear 
correlation. High diffusion in tissue predicts low cell densities (and vice versa). 
The line represents a least mean-square fit of the data. 
 A negative linear correlation is also observed between 3d cell 
density and D value (Fig. 13). The 3d cell density 	was 
computed based on the cancer region fraction 	 and the 
intrinsic cell density slope factor   (for cancer cell) and  
(for non-cancer cell) from 2d to 3d (Fig. 9): =	 ∗ ∗ + (1 − ) ∗ ∗ ,    (7) 
where is the ratio between the cancer area (KL1 stained 
tissue area) and the tumor area (total tissue area). The intrinsic 
cancer cell density 	  equals the number of cancer cells 
divided by the cancer region (KL1) area, and the intrinsic 
non-cancer cell density  equals the number of non-cancer 
cells divided by the non-cancer region area (non-KL1).  
  
Fig. 13.  Correlation between D value and 3d cell density. The Pearson 
correlation coefficient (γ) is −0.89, which represents a strong linear negative 
correlation. The line represents a least mean-square fit	 = (D). Inset: cell 
density map of tumor section at DWI resolution excluding the necrotic region 
(in black), which is identified in T1-weighted MRI (compare Fig. 11). 
E. Tumor cell count estimation 
 Given the D value of each voxel in the tumor DWI data, the 
3d cell density corresponding to each voxel is obtained by the 
mapping from the D value to the local cell density. We exclude 
the necrotic volume in the calculation of cell number. The cell 
number of the whole tumor is the sum of the local cell numbers 
of vital tumor voxel volumes (excluding necrosis),  =	∑ ( ) = ∑ ρ ( ) × 	 ( ) = ∑ ( ) × ( ). 
   (8) 
Here ( ) is the cell number of voxel , ( ) is the voxel 3d 
cell density, and ( ) is the voxel volume, (i) = 2.1	mm×2.1	mm × 6	mm = 	26.46	mm . The linear mapping ( ( )) 
is defined above (see Fig. 13). The total cell number of the lung 
tumor in this study is estimated as	2.57 × 10 . 
 The average cell density of the whole tumor is 5.9 ×10 /  computed by dividing the total cell number by 
the vital tumor volume. It is comparable to the average density 
of the tumor samples (S1-S7) 	6.28 × 10 / . If we 
compute the total tumor cell number by multiplying the vital 
tumor volume in the T1-weighted MRI data with the average 
cell density of the tumor samples, the cell count is 4.52 ×10 	 × 6.28 × 10 / 	= 2.84 × 10 .  
T1-weighted MRI seems to lead to a larger total tumor volume 
than DWI (4.35 × 10 ), but the difference between tumor 
cell load estimations through both methods is not large. 
Blocks S1 S2 S3 S4 S5 S6 S7 
D 2.985 1.632 1.095 1.809 1.963 2.064 2.404 
SD of 
D 
0.328 0.122 0.079 0.027 0.018 0.050 0.037 
 
V.  DISCUSSION AND CONCLUSION 
 Exemplified for a NSCLC patient, we here present a new 
pipeline for the estimation of tumor cell load in solid tumors 
based on the fusion of image processing techniques. As a result, 
tumor cell numbers may directly be inferred from the 
non-invasive DWI data, which is routinely available for cancer 
patients. The main novelties include: adaptive cell nuclei 
segmentation; model-based 3d cell nuclei density estimation 
from 2d cell nuclei data; cell number calculation based on the 
correlation between diffusion coefficient (D value) obtained 
from the DWI data and 3d cell densities. The inference of 3d 
nuclei density from 2d sections is crucial to estimate tumor cell 
load in each voxel of the DWI as well as the whole tumor. 
Despite the algorithm is simple and approaches nuclei shapes 
by simple ellipsoids, it could be validated using confocal 
micrographs of liver tissue to give reliable values, and verified 
with synthetic data (Supplementary1-A). The inference 
algorithm could further be refined by taking into account the 
nucleus volume distribution, permitting to identify correlations 
between the ellipsoid axes. However, we do not expect major 
differences for the questions studied in this paper. 
The representative tumor samples were separated from the 
tumor mass after surgical resection. The automatic histology 
evaluation was successfully validated by a pathologist, 
showing high accuracy of the algorithm. The radiologist 
localized the representative tumor sample, defined the tumor 
borders in the DWI, and calculated for each tumor sample its 
corresponding D value by averaging over all voxels belonging 
to the respective sample. Knowing the D values of the whole 
tumor and the relationship between the D values and cell 
densities, the total tumor cell number was finally obtained. 
 For the histological study of the selected tumor, the digital 
cell segmentation successfully distinguished cancer cells from 
non-cancer cells, and their respective fractions revealed tumor 
heterogeneity. The segmentation and classification perform 
very well (Table I), but might be further improved by applying 
an image-specific color deconvolution method [47]. 
Heterogeneity was also indicated by the inter tumor samples 
cell density standard deviation 	SD = 1700	cell/mm  
having been more than five times the standard deviation of the 
intra sample 	 density SD = 330	cell/mm .  The tumor 
region close to the necrosis part has much higher cell densities 
than the region merged with the lung tissue or pericardial fat. In 
DWI, a high D value was obtained in tumor regions with low 
cell density, while low D value was obtained for high cellularity 
region. The D value of the tumor samples ranges between 1.09 
and 2.98 × 10 / 	with mean value	1.99 × 10 / . 
The D value differences in DWI indicate the variation of local 
cell density of tumor samples, which ranges between 2917	cell/mm  and 	7684	cell/mm .  The model-based 
computed 3d tumor densities varying within the tumor by a 
factor of about 2 were within the range denoted in [48]. 
Moreover this spatial organization of cell densities in a tumor is 
coherent with classical solid tumor descriptions [49]. DWI may 
thus provide a non-invasive indicator of such microscale 
structure. 
 Our study may help to refine and adjust the patient-specific 
development of therapeutic strategies. This holds true for 
conventional cytostatic drugs (e.g. platin based regimens) and 
for highly selective enzyme inhibitors (e.g. the epidermal 
growth factor inhibitor erlotinib), which are currently used in 
the treatment of lung cancer. In addition, this algorithm may be 
beneficial for the personalized adjustment of novel therapeutic 
approaches such as bi-specific monoclonal antibodies (BiTE) 
or immunotherapeutic therapies. Here the knowledge of cell 
numbers (cancer and non-cancer), as well as vessel density 
(which is key for pharmacokinetics) may allow the precise 
fitting of drug concentrations and application modes in order to 
reduce side effects and to increase the drugs anti-tumor 
efficiency. Thus, differences in the diffusion coefficient (D 
value) could not only aid the diagnosis but also guide the 
therapeutic intervention. Our procedure, tested for one selected 
NSCLC patient, might straightforwardly be applied to other 
cancer types, for which specific biomarkers for cancer cells 
exist. Stains used in tissue preparation other than KL1, will also 
be successful as long as individual cell types (cancer and 
non-cancer) can be identified based on the morphology or 
epitope-based approaches. 
 Potential errors of our study may include a mis-fusion of the 
MRI imaging and pathology processing of tissue specimens. 
For example, the shrinkage of tissue samples after formalin 
fixation [50] (around 10% [51]), may affect the tumor size 
measurement and must be considered in the future for tumor 
volume and 2d/3d cell density estimations. The tissue 
deformation caused by cutting artifacts may be corrected by 
image registration [38], however, as was shown in this paper, 
the registration step is not compulsory (see Table I). 
Limitations of the anatomical MRI planning, such as tilts of less 
than 5° of the DWI plane vs. the histology plane, increase the 
difficulty of the co-registration of the histological tumor slide 
and MRI data; however, by slight variation of the included 
DWI voxels we verified the robustness of the obtained D values. 
The reproducibility of DWI in lung tumor is still under 
investigation, but the DWI data is reproducible in many organs 
and different tumor types [52]–[54]. 
   Concerning the time-consumption of the different steps: the 
histological data generation is the most tedious part, whereas its 
automated image analysis does not require much man-time 
(and even computational time: 1 slide takes about ~1h on a 
10-core computer). The DWI data acquisition and parameter 
estimation are both much shorter than for histology (~1h).  
A further question remains of how this finding might be 
applied in the clinics. If the relation of D value and 3d density is 
sufficiently general it could be applied to different tissues. 
However, as the D value reflects the sum of interactions with 
many obstacles, besides cell membranes such as 
macromolecules, fibers, desmoplastic reaction and 
vascularization, differences would be expected for different 
tissues, even if the qualitative behavior should not change as 
indicated by the negative correlation between cell density and 
ADC (D value in our notion) observed in different tumors and 
patients in literature [55]. To further test its validity, the 
proposed method must be tested on patients with different 
subtypes of NSCLC tumors (e.g. squamous cell carcinoma and 
adenocarcinoma) to study how far the relation changes. For 
application in the clinics, one solution, even if labor-intense, 
would therefore be to systematically explore the correlation 
between cell density and D value for different tumor types 
(including origin at different organs) to obtain calibration 
 
curves that could be used for patients after identification of 
their tumor subtype. As an alternative applicable approach in 
the clinics, latest results indicate that the relation between D 
value and cell density might be inferred from biopsies, that in 
case of NSCLC patients are routinely taken for diagnosis 
guided by non-invasive imaging techniques. The biopsies 
should be sampled from regions of different D-values.  
APPENDIX 
A. Surgery protocol 
The study protocol was approved by the local Ethics 
Committee of the University of Heidelberg (approval number 
S-249/2010). In our study, the tumor tissue (6.5 cm in diameter) 
was taken from a 72 year old patient with a NSCLC that was 
treated with an upper left lobe en-block resection including 
pericardial and mediastinal invaded parts (Fig. 1). Initial 
histology had been sampled by means of trans bronchial 
biopsy. The patient tumor, which was poorly differentiated 
squamous cell carcinoma, was classified as pT4 pN0 (0/27) 
pL2 G3 R2 (details given in Supplementary1-G) according to 
TNM cancer staging system [56].  
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